Perrigo | PRGO - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.67B 140M 2026-06
Abbott USD 25.51B 488M 2026-03
Bayer EUR 33.64B 1.66B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Coherus Biosciences USD 133.79M 72.25M 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Dr.Reddys Laboratories INR 299.33B 2.46B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
J&J USD 59.77B 601M 2026-06
Merck USD 36.68B 1.66B 2026-06
Nestle CHF 37.58B 5.61B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Reckitt Benckiser GBP 4.6B 287M 2024-12
Sanofi EUR 31.52B 1.36B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zoetis USD 6.36B 118M 2026-06